Vertex Pharmaceuticals Announces the Date of its Third Quarter 2006 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Oct. 9  /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will announce its third quarter 2006 financial results on Thursday, October 26, 2006 after the financial markets close.  The Company will host a conference call at 5:00 p.m. Eastern Time.  The conference call also will be webcast.

The live webcast will be available to all interested parties through Vertex's website, http://www.vrtx.com/, and will be archived on the Company's website until November 9, 2006.  To access the webcast, go to the investor section and select 'Events & Presentations.'  To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.

Lexiva is a registered trademark of the GlaxoSmithKline group of companies.

  Vertex's press releases are available at http://www.vrtx.com/.

  Vertex Contact:
  Lora Pike, Manager, Investor Relations, (617)-444-6755


DATASOURCE: Vertex Pharmaceuticals Incorporated



CONTACT: Lora Pike, Manager, Investor Relations of Vertex

Pharmaceuticals, [phone]



Web site:  http://www.vrtx.com/



Company News On-Call:  http://www.prnewswire.com/comp/938395.html 

Copyright